PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.

The acquisition broadens and extends Agilent’s product portfolio and customer offerings, particularly in the chemical and biopharmaceutical industries for the analysis of natural and synthetic polymers such as nucleic acids, proteins, monoclonal antibodies, polysaccharides, and synthetic plastic.

“We’re extremely pleased to have the PSS team join Agilent to help us expand our leadership in liquid chromatography and the GPC/SEC market,” said Jacob Thaysen, president, Agilent Life Sciences and Applied Markets Group. “The advanced PSS hardware, software, columns and reference materials we’re adding to our portfolio will enhance our offerings and ensure we deliver the broad spectrum of LC equipment, GPC/SEC analytics and software our customers value.”

By acquiring PSS, Agilent will also add a key software component to complement its lineup of GPC/SEC products. In addition, Agilent will be able to use its global presence to expand the use of PSS products and expertise more widely. Agilent customers in the chemical, biopharmaceutical and other key segments will now also be able to take advantage of PSS technology more broadly because of Agilent’s strong global presence in those markets.

“This is a very strategic move for PSS and Agilent,” said Thorsten Hofe, managing director at PSS. “Together we can provide our customers a full range of GPC and LC products and extend the reach of PSS products into new, fast-growing markets. It’s an exciting time for the PSS team.”

Founded in 1985, PSS is privately held and is based in Mainz, Germany, with additional operations in Amherst, Mass. Financial terms of Agilent’s acquisition of PSS were not disclosed.